IndraLab

Statements

USP22 activates cell stemness. 3 / 3
| 3
eidos
"Down-regulation of USP22 reduces cell stemness and enhances the sensitivity of pancreatic cancer cells to cisplatin by inactivating the Wnt / beta-catenin pathway ."
35623308
eidos
"Inhibition of USP22 reduced the cell stemness and augmented the sensitivity of PC cells to cisplatin by inhibiting the Wnt / beta-catenin pathway ."
35623308
eidos
"Jiang et al.18 pointed out that USP22 contributes to CRC cell stemness and decreases the sensitivity of CRC cells to chemoresistance via the Wnt / beta-Catenin pathway ."
34420031